NM_003953.6:c.170C>T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003953.6(MPZL1):c.170C>T(p.Thr57Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_003953.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPZL1 | NM_003953.6 | c.170C>T | p.Thr57Ile | missense_variant | Exon 2 of 6 | ENST00000359523.7 | NP_003944.1 | |
MPZL1 | NM_024569.5 | c.170C>T | p.Thr57Ile | missense_variant | Exon 2 of 5 | NP_078845.3 | ||
MPZL1 | NM_001146191.2 | c.170C>T | p.Thr57Ile | missense_variant | Exon 2 of 3 | NP_001139663.1 | ||
MPZL1 | XM_047433610.1 | c.-203C>T | 5_prime_UTR_variant | Exon 3 of 7 | XP_047289566.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250924Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135636
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461342Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 726988
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.170C>T (p.T57I) alteration is located in exon 2 (coding exon 2) of the MPZL1 gene. This alteration results from a C to T substitution at nucleotide position 170, causing the threonine (T) at amino acid position 57 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at